12:00 AM
 | 
Jul 22, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Cellectis preclinical data

Cellectis said UCART19 eradicated human leukemia cells that were transferred into mice. The company plans...

Read the full 52 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >